Astralis Pharmacy Private Limited

Astralis Pharmacy Private Limited - pharma in Kolkata, West Bengal, India. FY 2026 financials & compliance.
CIN U85195WB2007PTC112572 Incorporated 15 January 2007 ROC Kolkata HQ Kolkata, West Bengal, India
Active Private Limited Company pharma MSME · Medium
Data last updated
Revenue · FY 2024
₹6.23 Cr
▼ 90% YoY
Net profit · FY 2024
₹7.26 Lakh
Net margin 1.2%
EBITDA · FY 2024
₹9.54 Lakh
EBITDA margin 1.5%
Authorised capital
₹50.15 Cr
Registered with MCA
Paid-up capital
₹26.88 Cr
Issued & subscribed
Open charges
₹125 Cr
Satisfied ₹10.35 Cr
Company age
19 yrs
Est. 2007
Employees · EPFO
4
Provident fund records

About Astralis Pharmacy Private Limited

Data last updated:

Astralis Pharmacy Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 January 2007 and has been in existence for over 19 years.

The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U85195WB2007PTC112572. Its GSTIN is 19AAFCM0339L1Z9 (West Bengal). The company holds 4 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹50.15 Cr and a paid-up capital of ₹26.88 Cr. It is led by directors including Alok Roy and Aviral Roy.

Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at P41 Taratala Road, Kolkata, West Bengal, India – 700088.

As per the financials filed for FY 2024, the company reported a revenue of ₹6.23 Cr, a decline of 90% compared to the previous year. For the same year it recorded a net profit of ₹7.26 Lakh (net margin 1.2%) and EBITDA of ₹9.54 Lakh (EBITDA margin 1.5%). Revenue has declined at a compounded annual rate (CAGR) of 43% over three years and 24% over five years.

The company has about 4 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹125 Cr and satisfied charges of ₹10.35 Cr on record. Court records list 3 cases involving the company, including 3 filed by the company; 2 cases are pending. The company has 7 deals on record (5 secondary share transfers, 2 funding rounds), with disclosed funding of ₹8.01 Cr; the latest was in March 2024. The company has 11 MSME Form 1 returns on record between 2019 and 2023, listing 180 overdue payments to 50 micro and small suppliers.

Astralis Pharmacy Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-10-0020625). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website medicapharmacy.in.

Company details

CIN U85195WB2007PTC112572
Registration Number 112572
Incorporation Date 15 January 2007
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 26 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-WB-10-0020625
Key People
Alok Roy Director Aviral Roy Director Nirajnayan Pandeya Additional Director

Recognitions & Rankings of Astralis Pharmacy

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-WB-10-0020625

Contact details

Astralis Pharmacy Private Limited's registered office is in Kolkata, West Bengal. Its website is medicapharmacy.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    medicapharmacy.in
  • Registered Address
    P41 Taratala Road, Kolkata, West Bengal, India – 700088
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Astralis Pharmacy Private Limited, buy the company report.

Comprehensive company report
Astralis Pharmacy Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Astralis Pharmacy is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of Astralis Pharmacy Private Limited, buy the company report.

Financials of Astralis Pharmacy Private Limited

FY 2025 filings available

Astralis Pharmacy Private Limited reported revenue of ₹6.23 Cr (down 90% YoY) for FY 2024.

Revenue · FY 2024
₹6.23 Cr ▼ 90%
Net profit · FY 2024
₹7.26 Lakh margin 1.2%
EBITDA · FY 2024
₹9.54 Lakh margin 1.5%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 90%
3 years · compounded
▼ 43%
5 years · compounded
▼ 24%
EBITDA CAGR growth
1 year
▼ 99%
3 years · compounded
▼ 60%
5 years · compounded
▼ 42%

Revenue has declined at a compounded annual rate (CAGR) of 24% over five years, including a 90% fall in the latest year. EBITDA fell 99% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹9.54 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹7.26 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin1.5%
Net Profit Margin1.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Astralis Pharmacy Private Limited, buy the company report.

Board of directors of Astralis Pharmacy Private Limited

Astralis Pharmacy has 7 current directors and 19 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Alok Roy
Also directs: Sartoria Lifestyle & Fashion Private Limited, Confederation of Eastern Chambers of Commerce and Industry
Director02 Sep 20242 Years 2 MonthsCurrent
Aviral Roy
Also directs: Citadel Health Foundation, Obsidian Health Private Limited
Director02 Sep 20242 Years 2 MonthsCurrent
Nirajnayan Pandeya
Also directs: Akasi Foods and Hospitality Private Limited, Akasi Consultancy and Management Private Limited
Additional Director02 Feb 20251 Years 9 MonthsCurrent
Alex Kuruvilla
Also directs: Qikwell Technologies India Private Limited, Sri Naga Sai Healthcare Private Limited, Heilsa Healthcare Private Limited and 1 more
Additional Director02 Feb 20251 Years 9 MonthsCurrent
Chandan SinhaAdditional Director02 Feb 20251 Years 9 MonthsCurrent
Gandharv Roy
Also directs: A J Enterprises Ltd, Brewniverse Beverages Private Limited, Citadel Health Foundation and 1 more
Director02 Sep 20242 Years 2 MonthsCurrent
Showing 6 of 7 current directors. View all directors

Auditor

Astralis Pharmacy Private Limited is audited by Vineet Khetan & Associates for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Vineet Khetan & AssociatesFY 2023324428E

Shareholding

The shareholding of Astralis Pharmacy Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Astralis Pharmacy Private Limited, buy the company report.

Charges & borrowings

Open charges
₹125 Cr
Satisfied charges
₹10.35 Cr
Breakdown by lending institutions
Sbicap Trustee Company Limited₹125.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
24 Nov 2025101191421Sbicap Trustee Company Limited₹125 CrOpen
23 Nov 2018100236225Others₹2.6 CrSatisfied
07 Sep 2017100138047Axis Bank Limited₹3 CrSatisfied
24 Dec 200810145903Others₹2.25 CrSatisfied
29 Feb 200810093962Canara Bank₹2.5 CrSatisfied

To see the full charge records of Astralis Pharmacy Private Limited, buy the company report.

Total charge records: 5 View all charges

Deals & funding

Astralis Pharmacy Private Limited has 7 deals on record (5 secondary share transfers, 2 funding rounds), with disclosed funding of ₹8.01 Cr; the latest was in March 2024.

Total deals
7
Secondary share transfers
5
Funding rounds
2
Disclosed funding
₹8.01 Cr

Deals on record (5 of 7)

WhenDealAmountParties
Mar 2024Secondary share transferUndisclosedBuyer: an individual
Seller: Medica Synergie Private Limited, 3 individuals
Feb 2022Secondary share transferUndisclosedBuyer: Medica Synergie Private Limited
Seller: an individual
Apr 2021Secondary share transferUndisclosedBuyer: 4 individuals
Seller: an individual
Dec 2013Secondary share transferUndisclosedBuyer: 2 individuals
Seller: Medica Synergie Private Limited
Mar 2010Funding round₹3.02 CrInvestors: Medica Synergie Private Limited

To see the full deal history of Astralis Pharmacy Private Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Astralis Pharmacy Private Limited has 11 MSME Form 1 returns on record between 2019 and 2023, listing 180 overdue payments to 50 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 50)

SupplierAmount dueDue sinceReported on
an individual supplier
an individual supplier
Modern Care
Abhi Medico Private Limited
Zenithin Private Limited

To see the full MSME payment records of Astralis Pharmacy Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Astralis Pharmacy Private Limited has a workforce of 4 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.

Employee count
4
Active EPFO establishments
1
Employee growth
-20%

GST

Astralis Pharmacy has 4 GST registrations: 1 active and 3 cancelled or inactive.

Total GSTINs
4
Active
1
Cancelled / inactive
3
GSTINStateStatusRegistered on
19AAFCM0339L1Z9West BengalActive01 Jul 2017

To see the full GST registrations and return filing status of Astralis Pharmacy Private Limited, buy the company report.

Recent activity

Astralis Pharmacy Private Limited has 24 board changes on record since 2007: 7 appointments and 17 cessations. The latest: Alex Kuruvilla was appointed as Additional Director on 02 Feb 2025.

Charges
A charge with Sbicap Trustee Company Limited amounted to Rs. 125.00 Cr with Charge ID 101191421 was registered on 24 Nov 2025.
AGM
Astralis Pharmacy Private Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records.
Filing
Astralis Pharmacy Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata.
Appointed
Alex Kuruvilla was appointed as Additional Director.
Appointed
Chandan Sinha was appointed as Additional Director.
Appointed
Nirajnayan Pandeya was appointed as Additional Director.
Ceased
Aviral Roy ceased to be Additional Director.
Appointed
Alok Roy was appointed as Director.
Appointed
Aviral Roy was appointed as Director.
Appointed
Gandharv Roy was appointed as Director.
Appointed
Kavita Roy was appointed as Director.
Ceased
Naman Agarwal ceased to be Additional Director.

26 earlier events are in the company report.

Frequently asked questions

Astralis Pharmacy is an active private limited company based in Kolkata, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 January 2007 (19+ years old) and is registered under CIN U85195WB2007PTC112572.

Astralis Pharmacy has 7 current directors:

The latest financial statements of Astralis Pharmacy on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Astralis Pharmacy is 19AAFCM0339L1Z9, registered in West Bengal. The company has 4 GST registrations in all, of which 1 is active and 3 are cancelled or inactive.

The CIN (Corporate Identification Number) of Astralis Pharmacy is U85195WB2007PTC112572. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Astralis Pharmacy has 3 court cases on record: 3 filed by the company. 2 are pending.

Astralis Pharmacy was incorporated on 15 January 2007, making it 19+ years old. It is registered with the Registrar of Companies, Kolkata.

Astralis Pharmacy has 7 deals on record (5 secondary share transfers, 2 funding rounds), with disclosed funding of ₹8.01 Cr; the latest was in March 2024.

Alex Kuruvilla was appointed as Additional Director on 02 Feb 2025. Chandan Sinha was appointed as Additional Director on 02 Feb 2025. Nirajnayan Pandeya was appointed as Additional Director on 02 Feb 2025. Astralis Pharmacy has 24 board changes on record in total.

Yes, Astralis Pharmacy is registered as a medium enterprise under Udyam registration (number: UDYAM-WB-10-0020625).

Astralis Pharmacy has 11 MSME Form 1 returns on record between 2019 and 2023, listing 180 overdue payments to 50 micro and small suppliers. The latest return was filed on 29 Aug 2023.